Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lorena Lobo

Showing results (31-40 of 38) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 38 results.
British Journal of Haematology|September 19, 2023
Ratio of stemness to interferon signalling as a biomarker and therapeutic target of myeloproliferative neoplasm progression to acute myeloid leukaemiaFabíola Attié de Castro, Parinaz Mehdipour, Ankur Chakravarthy, et al.
Hematology, Transfusion and Cell Therapy|June 18, 2024
Diagnosis and management of acute promyelocytic leukemia: Brazilian consensus guidelines 2024 on behalf of the Brazilian Association of Hematology, Hemotherapy and Cellular TherapyLorena Lobo de Figueiredo-Pontes, Luiz Fernando Bazzo Catto, Maria de Lourdes Lopes Ferrari Chauffaille, et al.
Investigational New Drugs|January 6, 2021
NT157, an IGF1R-IRS1/2 inhibitor, exhibits antineoplastic effects in pre-clinical models of chronic myeloid leukemiaRenata Scopim-Ribeiro, João Agostinho Machado-Neto, Christopher A Eide, et al.
Frontiers in Immunology|October 10, 2022
Altered distribution and function of NK-cell subsets lead to impaired tumor surveillance in JAK2V617F myeloproliferative neoplasmsAmanda Fernandes de Oliveira Costa, Leticia Olops Marani, Thiago Mantello Bianco, et al.
Investigational New Drugs|November 27, 2021
STMN1 is highly expressed and contributes to clonogenicity in acute promyelocytic leukemia cellsHugo Passos Vicari, Juan Luiz Coelho-Silva, Diego A Pereira-Martins, et al.
Blood Advances|September 29, 2023
Telomeric repeat-containing RNA is dysregulated in acute myeloid leukemiaLuiz Fernando B Catto, Leonardo C Zanelatto, Flavia S Donaires, et al.
Science Translational Medicine|August 5, 2016
Targeted BMI1 inhibition impairs tumor growth in lung adenocarcinomas with low CEBPα expressionKol Jia Yong, Daniela S Basseres, Robert S Welner, et al.
Hematology, Transfusion and Cell Therapy|April 25, 2026
Criteria for referring pediatric and adult patients with hematological diseases to palliative care: Consensus of the Brazilian Association of Hematology, hemotherapy and cell therapy (2025)Amanda Pifano Soares Ferreira, Cecília Emerick Mendes Vaz, Laura Ferreira de Mesquita Ferraz, et al.
Pageof 4

Showing results (31-40 of 38) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 38 results.
British Journal of Haematology|September 19, 2023
Ratio of stemness to interferon signalling as a biomarker and therapeutic target of myeloproliferative neoplasm progression to acute myeloid leukaemiaFabíola Attié de Castro, Parinaz Mehdipour, Ankur Chakravarthy, et al.
Hematology, Transfusion and Cell Therapy|June 18, 2024
Diagnosis and management of acute promyelocytic leukemia: Brazilian consensus guidelines 2024 on behalf of the Brazilian Association of Hematology, Hemotherapy and Cellular TherapyLorena Lobo de Figueiredo-Pontes, Luiz Fernando Bazzo Catto, Maria de Lourdes Lopes Ferrari Chauffaille, et al.
Investigational New Drugs|January 6, 2021
NT157, an IGF1R-IRS1/2 inhibitor, exhibits antineoplastic effects in pre-clinical models of chronic myeloid leukemiaRenata Scopim-Ribeiro, João Agostinho Machado-Neto, Christopher A Eide, et al.
Frontiers in Immunology|October 10, 2022
Altered distribution and function of NK-cell subsets lead to impaired tumor surveillance in JAK2V617F myeloproliferative neoplasmsAmanda Fernandes de Oliveira Costa, Leticia Olops Marani, Thiago Mantello Bianco, et al.
Investigational New Drugs|November 27, 2021
STMN1 is highly expressed and contributes to clonogenicity in acute promyelocytic leukemia cellsHugo Passos Vicari, Juan Luiz Coelho-Silva, Diego A Pereira-Martins, et al.
Blood Advances|September 29, 2023
Telomeric repeat-containing RNA is dysregulated in acute myeloid leukemiaLuiz Fernando B Catto, Leonardo C Zanelatto, Flavia S Donaires, et al.
Science Translational Medicine|August 5, 2016
Targeted BMI1 inhibition impairs tumor growth in lung adenocarcinomas with low CEBPα expressionKol Jia Yong, Daniela S Basseres, Robert S Welner, et al.
Hematology, Transfusion and Cell Therapy|April 25, 2026
Criteria for referring pediatric and adult patients with hematological diseases to palliative care: Consensus of the Brazilian Association of Hematology, hemotherapy and cell therapy (2025)Amanda Pifano Soares Ferreira, Cecília Emerick Mendes Vaz, Laura Ferreira de Mesquita Ferraz, et al.
Pageof 4